Загрузка...
Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer's disease
After 15 years of research into Alzheimer's disease (AD) therapeutics, including billions of US dollars provided by federal agencies, pharmaceutical companies, and private foundations, there are still no meaningful therapies that can delay the onset or slow the progression of AD. An understandi...
Сохранить в:
| Опубликовано в: : | Br J Pharmacol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6715597/ https://ncbi.nlm.nih.gov/pubmed/30924124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14668 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|